z-logo
open-access-imgOpen Access
Recurrent cerebral infarctions in two brothers with antiphospholipid antibodies that block coagulation reactions.
Author(s) -
Dan Jacobson,
Jessica H. Lewis,
Franklin A. Bontempo,
Joel A. Spero,
M. V. Ragni,
O. M. Reinmuth
Publication year - 1986
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/01.str.17.1.98
Subject(s) - medicine , coagulation , cerebral infarction , antibody , systemic lupus erythematosus , precipitin , antiphospholipid syndrome , ouchterlony double immunodiffusion , immunology , lupus anticoagulant , disease , ischemia , antiserum
Inhibitors blocking coagulation reactions, often called lupus anticoagulants, are readily identifiable but rarely considered as risk factors for cerebral infarction. These inhibitors are inconsistently found in a number of diseases (often autoimmune) and after treatment with ceretain drugs and appear to be closely associated with, or identical to, antibodies to certain phospholipids. We have observed two brothers with these inhibitors who both experienced recurrent cerebral infarctions. Such familial occurrence has rarely been reported. In addition, some other family members were found to have depressed factor XII levels. Using the technique of double immunodiffusion, we found that the serum from these brothers formed precipitin lines against certain phospholipid substrates, lending further support to the antiphospholipid nature of this inhibitor.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom